{"type":"rich","version":"1.0","provider_name":"Transistor","provider_url":"https://transistor.fm","author_name":"India Tech Report","title":"India’s first S&T and innovation conclave, Eli Lilly’s $1 bln plan","html":"<iframe width=\"100%\" height=\"180\" frameborder=\"no\" scrolling=\"no\" seamless src=\"https://share.transistor.fm/e/a861eadf\"></iframe>","width":"100%","height":180,"duration":315,"description":"Daily brief on deep tech and climate tech from India and around the world.India’s Science and Tech minister Dr. Jitendra Singh (centre) at the curtain raiser for the country’s first science, tech and innovation conclave.Minister Dr. Jitendra Singh launches Emerging Science, Technology & Innovation ConclaveUnion Minister Dr. Jitendra Singh launched a curtain-raiser for the Emerging Science, Technology & Innovation Conclave (ESTIC-2025), according to a ministry press release yesterday. The three-day conclave, to be held in Delhi starting Nov. 3, will focus on technologies including semiconductors, AI, quantum computing, biotech, space, and clean energy. It is designed to be a platform for young innovators, startups, and researchers to showcase their solutions and connect with industry leaders.Listen to the episodeDPIIT and Thermo Fisher Scientific to support 500 biotech startupsIndia’s Department for Promotion of Industry and Internal Trade (DPIIT) has partnered Thermo Fisher Scientific to launch the BioVerse Challenge, a national programme aimed at supporting 500 biotech startups in India over the next three years, according to a press release from the commerce ministry. The collaboration will provide mentorship, access to advanced R&D facilities, and investor connections. This initiative is a key step towards achieving India’s vision of building a $300 billion bioeconomy by 2030.Eli Lilly to invest over $1 billion in India manufacturing expansionUS pharmaceutical company Eli Lilly will invest more than $1 billion to expand its manufacturing and supply capabilities in India, Reuters reports. The investment includes new contract manufacturing facilities and a new manufacturing and quality hub in Hyderabad. The company’s goal is to strengthen its global supply chain and leverage India’s skilled workforce to increase the availability of key medicines for conditions such as diabetes, obesity, and cancer.RoosterBio and Secretome Therapeutics complete large-scale...","thumbnail_url":"https://img.transistorcdn.com/klwtZi6_OVxR1RQx-EUqBBLq9JNmkk2p0xt3ov7-eeg/rs:fill:0:0:1/w:400/h:400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9kYjRi/MTNkNDVhMTVlOThm/MDM4ZmVlYjFmZGNl/OGFiNy5wbmc.webp","thumbnail_width":300,"thumbnail_height":300}